HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tissue and tumor distribution of C-penclomedine in rats.

Abstract
Penclomedine, a lipophilic alpha-picoline derivative, is undergoing clinical development presently because of its pronounced antitumor activity against intracerebral (i.c.) tumor xenografts. Penclomedine may be metabolized in vivo to a more potent compound. Although it may be useful in the treatment of brain tumors, the drug has caused significant neurotoxicity in early clinical trials. The possibility that antitumor activity and neurotoxicity may be mediated by different mechanisms prompted a study assessing the differential distribution of penclomedine and penclomedine metabolites to brain and i.c.-implanted tumors in rats. In the present study, quantitative autoradiographic analysis demonstrated a homogenous distribution of 14C-penclomedine in all organs within 1 h of administration. Levels of 14C-penclomedine in both i.c. and s.c. tumors were three times higher than in normal brain tissue. High-performance liquid chromatography combined with gas chromatography and mass spectrophotometry demonstrated that two metabolites, O-demethyl penclomedine and penclomic acid, were responsible for most of the plasma radioactivity. Penclomic acid was also the most common urinary metabolite of penclomedine. In liver samples, although a large number of metabolite peaks were detected, no parent compound could be identified. However, in tumors and all other tissues, penclomedine was the main compound detected. The finding of penclomedine in normal brain tissue indicates not only that this drug may be useful in tumors with normal blood-brain barrier function, but also that it may be directly neurotoxic.
AuthorsS O'Reilly, N R Hartman, S A Grossman, J M Strong, R F Struck, S Eller, G J Lesser, R C Donehower, E K Rowinsky
JournalClinical cancer research : an official journal of the American Association for Cancer Research (Clin Cancer Res) Vol. 2 Issue 3 Pg. 541-8 (Mar 1996) ISSN: 1078-0432 [Print] United States
PMID9816201 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antineoplastic Agents
  • Carbon Radioisotopes
  • Picolines
  • penclomedine
Topics
  • Animals
  • Antineoplastic Agents (pharmacokinetics)
  • Autoradiography
  • Brain (metabolism)
  • Carbon Radioisotopes
  • Kidney (metabolism)
  • Liver (metabolism)
  • Male
  • Neoplasms, Experimental (metabolism)
  • Picolines (pharmacokinetics)
  • Rats
  • Rats, Sprague-Dawley
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: